# Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

> **NCT04592198** · PHASE2 · COMPLETED · sponsor: **Xiamen LP Pharmaceutical Co., Ltd** · enrollment: 22 (actual)

## Conditions studied

- Nausea With Vomiting Chemotherapy-Induced

## Interventions

- **DRUG:** Palonosetron Hydrochloride Buccal Film 0.25 Mg
- **DRUG:** Palonosetron Hydrochloride Buccal Film 0.5 Mg
- **DRUG:** Palonosetron Hydrochloride, 0.25 Mg/5 mL Intravenous Solution

## Key facts

- **NCT ID:** NCT04592198
- **Lead sponsor:** Xiamen LP Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-03-25
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592198, "Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04592198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*